Fabian Gaessler

Fabian Gaessler is an Assistant Professor at the Universitat Pompeu Fabra (Department of Economics and Business) and an Affiliated Research Fellow at the Max Planck Institute for Innovation and Competition since 2022. He also serves as an Affiliated Professor at the Barcelona School of Economics and previously held academic roles at IESE Business School (2019) and Technical University of Munich (2018–2019).

Education:

• Doctoral Studies (2013–2015) at Max Planck Institute for Innovation and Competition
• Postgraduate Law and Economics (2010–2013) at International Max Planck Research School
• M.Sc. in Organization, Management and Governance (2009–2010) at London School of Economics
• Honors Degree in Technology Management (2008–2011) at Center for Digital Technology and Management, Munich
• B.Sc. in Business Administration (2005–2009) at LMU Munich and University of California, Santa Barbara

Research Interests focus on innovation economics, patent policy, and AI applications in strategic decision-making. His work bridges empirical industrial organization and technology management, with key contributions on patent enforcement, data exclusivity, and human-AI collaboration in innovation.

Key Article Trends include:

• Patent oppositions and follow-on innovation
• AI as a training tool in strategic environments
• Market exclusivity impacts on pharmaceutical R&D
• Physical capital shocks in scientific productivity
• Bifurcated patent litigation systems
• Scientific quality and patent value linkages

Scientific Awards:

• 2017: Otto Hahn Medal of the Max Planck Society

Advising and Grants: While direct student advisement is not explicitly listed, Gaessler has collaborated extensively with scholars like Dietmar Harhoff, Karin Hoisl, and Henning Piezunka. His research has been supported by institutions including the Max Planck Society, European Commission, and ZEW.

Labs and Teams: Affiliated with the Innovation and Entrepreneurship Research group at Max Planck Institute for Innovation and Competition. His work involves cross-institutional collaborations with European patent litigation experts and biomedical research teams.